KCG
GENE

Knight Capital Group’s Genetic Technologies Ltd. GENE Stock Holding History

Knight Capital Group’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$33K Buy
+142
New +$36.8K ﹤0.01% 3111

Other funds holding GENE

AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
APU
Alpine Partners USVI St. Thomas, U.S. Virgin Islands $30.1M AUM
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Knight Capital Group's GENE Position: Q2 2013 in Review

Knight Capital Group opened a new position in Genetic Technologies Ltd. (GENE) in Q2 2013: 142 shares worth $33K. The stake represents ﹤0.01% of the portfolio and ranks #3111 among its holdings.

6 funds tracked by Wall St. Rank hold GENE as of Q2 2013.

  • Knight Capital Group held 142 shares of Genetic Technologies Ltd. worth $33K as of Q2 2013.
  • Genetic Technologies Ltd. was a new Knight Capital Group position in Q2 2013.
  • Genetic Technologies Ltd. made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #3111 holding.
  • 6 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.